AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MAPS

Share Issue/Capital Change Jul 8, 2022

4072_dva_2022-07-08_ab8a6fb6-e544-4180-be92-2b1f3aac455b.pdf

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

Informazione
Regolamentata n.
20153-56-2022
Data/Ora Ricezione
08 Luglio 2022
10:34:26
Euronext Growth Milan
Societa' : MAPS
Identificativo
Informazione
Regolamentata
: 164637
Nome utilizzatore : MAPSN03 - Ciscato
Tipologia : REGEM
Data/Ora Ricezione : 08 Luglio 2022 10:34:26
Data/Ora Inizio
Diffusione presunta
: 08 Luglio 2022 10:34:27
Oggetto : MAPS: OUTCOMES OF THE 2019-2021
STOCK OPTION AND STOCK GRANT
PLANS
Testo del comunicato

Vedi allegato.

MAPS: OUTCOMES OF THE 2019-2021 STOCK OPTION AND STOCK GRANT PLANS

Parma, 08 July 2022

MAPS (MAPS:IM; IT0005364333), Innovative SME listed on Euronext Growth Milan operating in the digital transformation sector, following up on the press releases issued on 25 May 2019 and 24 January 2020, announces the outcomes of the 2019-2021 Stock Option and Stock Grant Plans approved by the Shareholders' Meeting on 11 February 2019.

In execution of the 2019-2021 Stock Grant Plan and based on prior verification of the existence of the conditions pursuant to the relevant Regulation, 1,350 Bonus Shares were allocated free of charge to a Company Top Manager (the "Beneficiary"), of which 30% in the form of "EBITDA Shares" and 70% in the form of "Performance Shares".

In execution of the 2019-2021 Stock Option Plan, and based on prior verification of the existence of the conditions pursuant to the relevant Regulation, 52,085 newly issued ordinary shares were allocated to ten Group employees (the "Beneficiaries") following the exercise of 52,085 options accrued by the Beneficiaries, of which 50% in the form of "EBITDA Options" and 50% in the form of "Performance Options", through the payment of the exercise price of Euro 1.90, equal to the placement price of the MAPS shares at the IPO phase.

As a result of the closing of the Stock Option and Stock Grant Plans, MAPS' share capital will therefore stand at Euro 1.379.895,48, composed of 11,712,229 ordinary shares, with no par value.

The Company will publish the notice of change in share capital after the share capital increase has been filed with the competent Companies Register.

MAPS GROUP

Founded in 2002, MAPS is an Innovative SME operating in the digital transformation sector. With its registered office in Parma and with approximately 200 employees, it produces and distributes software for the analysis of big data that allows client companies to manage and analyse large quantities of data and information, helping them make strategic and operational decisions and define new business models. Operating in a context characterised by high growth potential: investments in digital transformation estimated for the three-year period 2022-2024 are approximately \$6.3 billion with a CAGR of 16.5% (Source: IDC). MAPS operates through three business units focused respectively on the Health, Energy and Sustainability (ESG) sectors, providing solutions to a portfolio of over 500 highly loyal customers. Through its Patient Journey product line, MAPS is positioned as a leader in the field of patient reception in healthcare facilities, presiding over the market with over 1,500 installations, managing 36 million patient admissions nationwide. Thanks to ROSE, an intelligent energy management platform, MAPS now supports the main trends in the energy transition leading to the emergence of new business models based on flexibility, such as the energy communities. In terms of sustainability, GZOOM's value governance solution is now used by over 70 Italian organisations to measure objectives, manage risks, and share their non-financial performance. The Group is investing on an ongoing basis in R&D: in the last 3 years it has allocated a total of €5.3 million to innovation. The Research & Solutions division, set up in 2016, is responsible for identifying market needs and evolving software solutions.

The Group closes 2021 with consolidated revenues of €21.5 million (+20% compared to 2020) - with significant growth in revenues from Healthcare (+62%) and ESG (+69%) markets - and EBITDA of €5 million (23.3% EBITDA Margin). In the last three years MAPS has more than tripled its revenues from its proprietary solutions (15.2 million in 2021, or 72% of consolidated revenues). The company is characterised by high levels of recurring revenues: recurring fee revenues reached 34% of consolidated operating revenues in 2021 (CAGR 2018-2021 of 38%). The Group's organic growth has been accompanied by significant M&A activity, with the acquisition of IG Consulting (2011), Artexe (2018), Roialty (2019), SCS Computers (2020), IASI (2021) and I-TEL (2022).

Release available on and on www.mapsgroup.it

CONTACTS

MAPS T +390521052300 [email protected]

Marco Ciscato – Investor Relations Manager [email protected]

EURONEXT GROWTH ADVISOR BPER Banca | T +390272 74 92 29 [email protected]

INVESTOR RELATIONS & FINANCIAL MEDIA IR Top Consulting | T +390245473884 Maria Antonietta Pireddu, [email protected] Domenico Gentile, [email protected] │ Antonio Buozzi, [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.